Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Rossari Biotech Financial Results

Rossari Biotech reported consolidated total income of ₹2,418.74 Crore for FY26. The Board recommended a final dividend of ₹0.50 per share (25%) and appointed Mr. Udeypaul Singh Gill as an Independent Director. Additionally, the company approved a new R&D facility in Navi Mumbai and an update on its capacity expansion project.

Key figures
Value₹2,419 Cr
Source

NSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rossari Biotech Ltd: key numbers

Share price
₹407.35
Market cap
₹2,256 Cr
Revenue (annual)
₹2,396 Cr
Net profit (annual)
₹149.2 Cr
P/E (TTM)
14.8×Sector 33.9×
Promoter holding
68.14%+0.00% QoQ
FII holding
1.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rossari Biotech Ltd

All →

Other financial results announcements

All →
23:13 IST BSE
Financial ResultsHEG Advanced Materials Ltd HEGAM

HEG Advanced Materials Q2 FY27 Results: Net Profit ₹306.1 Cr, Up 58.4% YoY

HEG Advanced Materials Ltd reported revenue from operations of ₹429.9 Cr (+144.4% YoY) and net profit of ₹306.1 Cr (+58.4% YoY) for Q2 FY27.

Key figure
Net profit ₹306.1 Cr · +58.4% YoY